You are here: Industry Insights > REGENT

News List

Regent Pacific Receives HK$24.96 million After Clinical Trial Approval For FORTACIN(TM) Has Been Obtained prnasia
April 02, 2021
Regent Pacific Group Limited, a specialist healthcare, wellness and life sciences investment group is pleased to announce that the Group has received a payment of US$3.20 million (approximately HK$24.96 million) before deduction of PRC withholding ...
Carmine, Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies americanpharmaceuticalreview
July 09, 2020
Carmine Therapeutics has signed a research collaboration agreement with Takeda to discover, develop and commercialize non-viral gene therapies for two rare disease targets using Carmine's REGENT technology, based on red blood cell extracellular vesicles.
Takeda forms $900m research alliance with Carmine Therapeutics pharmaceutical-technology
July 01, 2020
Japanese pharmaceutical giant Takeda Pharmaceutical has entered into a research collaboration agreement with US-based Carmine Therapeutics for the discovery, development and commercialisation of rare disease therapies.